Global Personalized Medicine for Cancer Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Personalized Medicine for Cancer market size was valued at US$ million in 2023. With growing demand in downstream market, the Personalized Medicine for Cancer is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Personalized Medicine for Cancer market. Personalized Medicine for Cancer are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Medicine for Cancer. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Medicine for Cancer market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Personalized Medicine for Cancer market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personalized Medicine for Cancer market. It may include historical data, market segmentation by Type (e.g., Immunotherapy, Targeted Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Medicine for Cancer market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personalized Medicine for Cancer market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Medicine for Cancer industry. This include advancements in Personalized Medicine for Cancer technology, Personalized Medicine for Cancer new entrants, Personalized Medicine for Cancer new investment, and other innovations that are shaping the future of Personalized Medicine for Cancer.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Medicine for Cancer market. It includes factors influencing customer ' purchasing decisions, preferences for Personalized Medicine for Cancer product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personalized Medicine for Cancer market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personalized Medicine for Cancer market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personalized Medicine for Cancer market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personalized Medicine for Cancer industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Medicine for Cancer market.
Market Segmentation:
Personalized Medicine for Cancer market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Personalized Medicine for Cancer market size was valued at US$ million in 2023. With growing demand in downstream market, the Personalized Medicine for Cancer is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Personalized Medicine for Cancer market. Personalized Medicine for Cancer are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Personalized Medicine for Cancer. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Personalized Medicine for Cancer market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Personalized Medicine for Cancer market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Personalized Medicine for Cancer market. It may include historical data, market segmentation by Type (e.g., Immunotherapy, Targeted Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Personalized Medicine for Cancer market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Personalized Medicine for Cancer market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Personalized Medicine for Cancer industry. This include advancements in Personalized Medicine for Cancer technology, Personalized Medicine for Cancer new entrants, Personalized Medicine for Cancer new investment, and other innovations that are shaping the future of Personalized Medicine for Cancer.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Personalized Medicine for Cancer market. It includes factors influencing customer ' purchasing decisions, preferences for Personalized Medicine for Cancer product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Personalized Medicine for Cancer market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Personalized Medicine for Cancer market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Personalized Medicine for Cancer market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Personalized Medicine for Cancer industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Personalized Medicine for Cancer market.
Market Segmentation:
Personalized Medicine for Cancer market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Hormone Therapy
- Others
- Breast Cancer
- Blood Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Skin Cancer
- Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- GlaxoSmithKline
- Novartis
- Sanofi
- Pfizer
- Amgen
- Merck
- Bristol-Myers Squibb
- Ariad Pharmaceuticals (Takeda)
- Eli Lilly
- Roche
- Boehringer Ingelheim
- Johnson and Johnson
- Teva Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Personalized Medicine for Cancer Market Size 2019-2030
2.1.2 Personalized Medicine for Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Medicine for Cancer Segment by Type
2.2.1 Immunotherapy
2.2.2 Targeted Therapy
2.2.3 Chemotherapy
2.2.4 Hormone Therapy
2.2.5 Others
2.3 Personalized Medicine for Cancer Market Size by Type
2.3.1 Personalized Medicine for Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
2.4 Personalized Medicine for Cancer Segment by Application
2.4.1 Breast Cancer
2.4.2 Blood Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Skin Cancer
2.4.6 Lung Cancer
2.4.7 Others
2.5 Personalized Medicine for Cancer Market Size by Application
2.5.1 Personalized Medicine for Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
3 PERSONALIZED MEDICINE FOR CANCER MARKET SIZE BY PLAYER
3.1 Personalized Medicine for Cancer Market Size Market Share by Players
3.1.1 Global Personalized Medicine for Cancer Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicine for Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicine for Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINE FOR CANCER BY REGIONS
4.1 Personalized Medicine for Cancer Market Size by Regions (2019-2024)
4.2 Americas Personalized Medicine for Cancer Market Size Growth (2019-2024)
4.3 APAC Personalized Medicine for Cancer Market Size Growth (2019-2024)
4.4 Europe Personalized Medicine for Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Medicine for Cancer Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Personalized Medicine for Cancer Market Size by Country (2019-2024)
5.2 Americas Personalized Medicine for Cancer Market Size by Type (2019-2024)
5.3 Americas Personalized Medicine for Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Medicine for Cancer Market Size by Region (2019-2024)
6.2 APAC Personalized Medicine for Cancer Market Size by Type (2019-2024)
6.3 APAC Personalized Medicine for Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Personalized Medicine for Cancer by Country (2019-2024)
7.2 Europe Personalized Medicine for Cancer Market Size by Type (2019-2024)
7.3 Europe Personalized Medicine for Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Personalized Medicine for Cancer by Region (2019-2024)
8.2 Middle East & Africa Personalized Medicine for Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERSONALIZED MEDICINE FOR CANCER MARKET FORECAST
10.1 Global Personalized Medicine for Cancer Forecast by Regions (2025-2030)
10.1.1 Global Personalized Medicine for Cancer Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Medicine for Cancer Forecast
10.1.3 APAC Personalized Medicine for Cancer Forecast
10.1.4 Europe Personalized Medicine for Cancer Forecast
10.1.5 Middle East & Africa Personalized Medicine for Cancer Forecast
10.2 Americas Personalized Medicine for Cancer Forecast by Country (2025-2030)
10.2.1 United States Personalized Medicine for Cancer Market Forecast
10.2.2 Canada Personalized Medicine for Cancer Market Forecast
10.2.3 Mexico Personalized Medicine for Cancer Market Forecast
10.2.4 Brazil Personalized Medicine for Cancer Market Forecast
10.3 APAC Personalized Medicine for Cancer Forecast by Region (2025-2030)
10.3.1 China Personalized Medicine for Cancer Market Forecast
10.3.2 Japan Personalized Medicine for Cancer Market Forecast
10.3.3 Korea Personalized Medicine for Cancer Market Forecast
10.3.4 Southeast Asia Personalized Medicine for Cancer Market Forecast
10.3.5 India Personalized Medicine for Cancer Market Forecast
10.3.6 Australia Personalized Medicine for Cancer Market Forecast
10.4 Europe Personalized Medicine for Cancer Forecast by Country (2025-2030)
10.4.1 Germany Personalized Medicine for Cancer Market Forecast
10.4.2 France Personalized Medicine for Cancer Market Forecast
10.4.3 UK Personalized Medicine for Cancer Market Forecast
10.4.4 Italy Personalized Medicine for Cancer Market Forecast
10.4.5 Russia Personalized Medicine for Cancer Market Forecast
10.5 Middle East & Africa Personalized Medicine for Cancer Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Medicine for Cancer Market Forecast
10.5.2 South Africa Personalized Medicine for Cancer Market Forecast
10.5.3 Israel Personalized Medicine for Cancer Market Forecast
10.5.4 Turkey Personalized Medicine for Cancer Market Forecast
10.5.5 GCC Countries Personalized Medicine for Cancer Market Forecast
10.6 Global Personalized Medicine for Cancer Forecast by Type (2025-2030)
10.7 Global Personalized Medicine for Cancer Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Personalized Medicine for Cancer Product Offered
11.1.3 Bayer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Personalized Medicine for Cancer Product Offered
11.2.3 GlaxoSmithKline Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Personalized Medicine for Cancer Product Offered
11.3.3 Novartis Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Personalized Medicine for Cancer Product Offered
11.4.3 Sanofi Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Personalized Medicine for Cancer Product Offered
11.5.3 Pfizer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Personalized Medicine for Cancer Product Offered
11.6.3 Amgen Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Personalized Medicine for Cancer Product Offered
11.7.3 Merck Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Personalized Medicine for Cancer Product Offered
11.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 Ariad Pharmaceuticals (Takeda)
11.9.1 Ariad Pharmaceuticals (Takeda) Company Information
11.9.2 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Offered
11.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ariad Pharmaceuticals (Takeda) Main Business Overview
11.9.5 Ariad Pharmaceuticals (Takeda) Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Personalized Medicine for Cancer Product Offered
11.10.3 Eli Lilly Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Roche
11.11.1 Roche Company Information
11.11.2 Roche Personalized Medicine for Cancer Product Offered
11.11.3 Roche Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Roche Main Business Overview
11.11.5 Roche Latest Developments
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Information
11.12.2 Boehringer Ingelheim Personalized Medicine for Cancer Product Offered
11.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Boehringer Ingelheim Main Business Overview
11.12.5 Boehringer Ingelheim Latest Developments
11.13 Johnson and Johnson
11.13.1 Johnson and Johnson Company Information
11.13.2 Johnson and Johnson Personalized Medicine for Cancer Product Offered
11.13.3 Johnson and Johnson Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Johnson and Johnson Main Business Overview
11.13.5 Johnson and Johnson Latest Developments
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Information
11.14.2 Teva Pharmaceuticals Personalized Medicine for Cancer Product Offered
11.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Teva Pharmaceuticals Main Business Overview
11.14.5 Teva Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Personalized Medicine for Cancer Market Size 2019-2030
2.1.2 Personalized Medicine for Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Personalized Medicine for Cancer Segment by Type
2.2.1 Immunotherapy
2.2.2 Targeted Therapy
2.2.3 Chemotherapy
2.2.4 Hormone Therapy
2.2.5 Others
2.3 Personalized Medicine for Cancer Market Size by Type
2.3.1 Personalized Medicine for Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
2.4 Personalized Medicine for Cancer Segment by Application
2.4.1 Breast Cancer
2.4.2 Blood Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Skin Cancer
2.4.6 Lung Cancer
2.4.7 Others
2.5 Personalized Medicine for Cancer Market Size by Application
2.5.1 Personalized Medicine for Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
3 PERSONALIZED MEDICINE FOR CANCER MARKET SIZE BY PLAYER
3.1 Personalized Medicine for Cancer Market Size Market Share by Players
3.1.1 Global Personalized Medicine for Cancer Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicine for Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicine for Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERSONALIZED MEDICINE FOR CANCER BY REGIONS
4.1 Personalized Medicine for Cancer Market Size by Regions (2019-2024)
4.2 Americas Personalized Medicine for Cancer Market Size Growth (2019-2024)
4.3 APAC Personalized Medicine for Cancer Market Size Growth (2019-2024)
4.4 Europe Personalized Medicine for Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Personalized Medicine for Cancer Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Personalized Medicine for Cancer Market Size by Country (2019-2024)
5.2 Americas Personalized Medicine for Cancer Market Size by Type (2019-2024)
5.3 Americas Personalized Medicine for Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Personalized Medicine for Cancer Market Size by Region (2019-2024)
6.2 APAC Personalized Medicine for Cancer Market Size by Type (2019-2024)
6.3 APAC Personalized Medicine for Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Personalized Medicine for Cancer by Country (2019-2024)
7.2 Europe Personalized Medicine for Cancer Market Size by Type (2019-2024)
7.3 Europe Personalized Medicine for Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Personalized Medicine for Cancer by Region (2019-2024)
8.2 Middle East & Africa Personalized Medicine for Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERSONALIZED MEDICINE FOR CANCER MARKET FORECAST
10.1 Global Personalized Medicine for Cancer Forecast by Regions (2025-2030)
10.1.1 Global Personalized Medicine for Cancer Forecast by Regions (2025-2030)
10.1.2 Americas Personalized Medicine for Cancer Forecast
10.1.3 APAC Personalized Medicine for Cancer Forecast
10.1.4 Europe Personalized Medicine for Cancer Forecast
10.1.5 Middle East & Africa Personalized Medicine for Cancer Forecast
10.2 Americas Personalized Medicine for Cancer Forecast by Country (2025-2030)
10.2.1 United States Personalized Medicine for Cancer Market Forecast
10.2.2 Canada Personalized Medicine for Cancer Market Forecast
10.2.3 Mexico Personalized Medicine for Cancer Market Forecast
10.2.4 Brazil Personalized Medicine for Cancer Market Forecast
10.3 APAC Personalized Medicine for Cancer Forecast by Region (2025-2030)
10.3.1 China Personalized Medicine for Cancer Market Forecast
10.3.2 Japan Personalized Medicine for Cancer Market Forecast
10.3.3 Korea Personalized Medicine for Cancer Market Forecast
10.3.4 Southeast Asia Personalized Medicine for Cancer Market Forecast
10.3.5 India Personalized Medicine for Cancer Market Forecast
10.3.6 Australia Personalized Medicine for Cancer Market Forecast
10.4 Europe Personalized Medicine for Cancer Forecast by Country (2025-2030)
10.4.1 Germany Personalized Medicine for Cancer Market Forecast
10.4.2 France Personalized Medicine for Cancer Market Forecast
10.4.3 UK Personalized Medicine for Cancer Market Forecast
10.4.4 Italy Personalized Medicine for Cancer Market Forecast
10.4.5 Russia Personalized Medicine for Cancer Market Forecast
10.5 Middle East & Africa Personalized Medicine for Cancer Forecast by Region (2025-2030)
10.5.1 Egypt Personalized Medicine for Cancer Market Forecast
10.5.2 South Africa Personalized Medicine for Cancer Market Forecast
10.5.3 Israel Personalized Medicine for Cancer Market Forecast
10.5.4 Turkey Personalized Medicine for Cancer Market Forecast
10.5.5 GCC Countries Personalized Medicine for Cancer Market Forecast
10.6 Global Personalized Medicine for Cancer Forecast by Type (2025-2030)
10.7 Global Personalized Medicine for Cancer Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Personalized Medicine for Cancer Product Offered
11.1.3 Bayer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Personalized Medicine for Cancer Product Offered
11.2.3 GlaxoSmithKline Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Personalized Medicine for Cancer Product Offered
11.3.3 Novartis Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Personalized Medicine for Cancer Product Offered
11.4.3 Sanofi Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Personalized Medicine for Cancer Product Offered
11.5.3 Pfizer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Personalized Medicine for Cancer Product Offered
11.6.3 Amgen Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Personalized Medicine for Cancer Product Offered
11.7.3 Merck Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Personalized Medicine for Cancer Product Offered
11.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bristol-Myers Squibb Main Business Overview
11.8.5 Bristol-Myers Squibb Latest Developments
11.9 Ariad Pharmaceuticals (Takeda)
11.9.1 Ariad Pharmaceuticals (Takeda) Company Information
11.9.2 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Offered
11.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ariad Pharmaceuticals (Takeda) Main Business Overview
11.9.5 Ariad Pharmaceuticals (Takeda) Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Personalized Medicine for Cancer Product Offered
11.10.3 Eli Lilly Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Roche
11.11.1 Roche Company Information
11.11.2 Roche Personalized Medicine for Cancer Product Offered
11.11.3 Roche Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Roche Main Business Overview
11.11.5 Roche Latest Developments
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Information
11.12.2 Boehringer Ingelheim Personalized Medicine for Cancer Product Offered
11.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Boehringer Ingelheim Main Business Overview
11.12.5 Boehringer Ingelheim Latest Developments
11.13 Johnson and Johnson
11.13.1 Johnson and Johnson Company Information
11.13.2 Johnson and Johnson Personalized Medicine for Cancer Product Offered
11.13.3 Johnson and Johnson Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Johnson and Johnson Main Business Overview
11.13.5 Johnson and Johnson Latest Developments
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Information
11.14.2 Teva Pharmaceuticals Personalized Medicine for Cancer Product Offered
11.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Teva Pharmaceuticals Main Business Overview
11.14.5 Teva Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Personalized Medicine for Cancer Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immunotherapy
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Hormone Therapy
Table 6. Major Players of Others
Table 7. Personalized Medicine for Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 10. Personalized Medicine for Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 13. Global Personalized Medicine for Cancer Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Personalized Medicine for Cancer Revenue Market Share by Player (2019-2024)
Table 15. Personalized Medicine for Cancer Key Players Head office and Products Offered
Table 16. Personalized Medicine for Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Personalized Medicine for Cancer Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Personalized Medicine for Cancer Market Size Market Share by Regions (2019-2024)
Table 21. Global Personalized Medicine for Cancer Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Personalized Medicine for Cancer Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Personalized Medicine for Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Personalized Medicine for Cancer Market Size Market Share by Country (2019-2024)
Table 25. Americas Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 27. Americas Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 29. APAC Personalized Medicine for Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Personalized Medicine for Cancer Market Size Market Share by Region (2019-2024)
Table 31. APAC Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 33. APAC Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 35. Europe Personalized Medicine for Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Personalized Medicine for Cancer Market Size Market Share by Country (2019-2024)
Table 37. Europe Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 39. Europe Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Personalized Medicine for Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Personalized Medicine for Cancer
Table 48. Key Market Challenges & Risks of Personalized Medicine for Cancer
Table 49. Key Industry Trends of Personalized Medicine for Cancer
Table 50. Global Personalized Medicine for Cancer Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Personalized Medicine for Cancer Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Personalized Medicine for Cancer Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Personalized Medicine for Cancer Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Bayer Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 55. Bayer Personalized Medicine for Cancer Product Offered
Table 56. Bayer Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Bayer Main Business
Table 58. Bayer Latest Developments
Table 59. GlaxoSmithKline Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 60. GlaxoSmithKline Personalized Medicine for Cancer Product Offered
Table 61. GlaxoSmithKline Main Business
Table 62. GlaxoSmithKline Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GlaxoSmithKline Latest Developments
Table 64. Novartis Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 65. Novartis Personalized Medicine for Cancer Product Offered
Table 66. Novartis Main Business
Table 67. Novartis Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Novartis Latest Developments
Table 69. Sanofi Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 70. Sanofi Personalized Medicine for Cancer Product Offered
Table 71. Sanofi Main Business
Table 72. Sanofi Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Sanofi Latest Developments
Table 74. Pfizer Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 75. Pfizer Personalized Medicine for Cancer Product Offered
Table 76. Pfizer Main Business
Table 77. Pfizer Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Pfizer Latest Developments
Table 79. Amgen Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 80. Amgen Personalized Medicine for Cancer Product Offered
Table 81. Amgen Main Business
Table 82. Amgen Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Amgen Latest Developments
Table 84. Merck Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 85. Merck Personalized Medicine for Cancer Product Offered
Table 86. Merck Main Business
Table 87. Merck Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Merck Latest Developments
Table 89. Bristol-Myers Squibb Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 90. Bristol-Myers Squibb Personalized Medicine for Cancer Product Offered
Table 91. Bristol-Myers Squibb Main Business
Table 92. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Bristol-Myers Squibb Latest Developments
Table 94. Ariad Pharmaceuticals (Takeda) Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 95. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Offered
Table 96. Ariad Pharmaceuticals (Takeda) Main Business
Table 97. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Ariad Pharmaceuticals (Takeda) Latest Developments
Table 99. Eli Lilly Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 100. Eli Lilly Personalized Medicine for Cancer Product Offered
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Eli Lilly Latest Developments
Table 104. Roche Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 105. Roche Personalized Medicine for Cancer Product Offered
Table 106. Roche Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Roche Main Business
Table 108. Roche Latest Developments
Table 109. Boehringer Ingelheim Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 110. Boehringer Ingelheim Personalized Medicine for Cancer Product Offered
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Boehringer Ingelheim Latest Developments
Table 114. Johnson and Johnson Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 115. Johnson and Johnson Personalized Medicine for Cancer Product Offered
Table 116. Johnson and Johnson Main Business
Table 117. Johnson and Johnson Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Johnson and Johnson Latest Developments
Table 119. Teva Pharmaceuticals Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 120. Teva Pharmaceuticals Personalized Medicine for Cancer Product Offered
Table 121. Teva Pharmaceuticals Main Business
Table 122. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Teva Pharmaceuticals Latest Developments
Table 1. Personalized Medicine for Cancer Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immunotherapy
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Hormone Therapy
Table 6. Major Players of Others
Table 7. Personalized Medicine for Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 10. Personalized Medicine for Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 13. Global Personalized Medicine for Cancer Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Personalized Medicine for Cancer Revenue Market Share by Player (2019-2024)
Table 15. Personalized Medicine for Cancer Key Players Head office and Products Offered
Table 16. Personalized Medicine for Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Personalized Medicine for Cancer Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Personalized Medicine for Cancer Market Size Market Share by Regions (2019-2024)
Table 21. Global Personalized Medicine for Cancer Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Personalized Medicine for Cancer Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Personalized Medicine for Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Personalized Medicine for Cancer Market Size Market Share by Country (2019-2024)
Table 25. Americas Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 27. Americas Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 29. APAC Personalized Medicine for Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Personalized Medicine for Cancer Market Size Market Share by Region (2019-2024)
Table 31. APAC Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 33. APAC Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 35. Europe Personalized Medicine for Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Personalized Medicine for Cancer Market Size Market Share by Country (2019-2024)
Table 37. Europe Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 39. Europe Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Personalized Medicine for Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Personalized Medicine for Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Personalized Medicine for Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Personalized Medicine for Cancer
Table 48. Key Market Challenges & Risks of Personalized Medicine for Cancer
Table 49. Key Industry Trends of Personalized Medicine for Cancer
Table 50. Global Personalized Medicine for Cancer Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Personalized Medicine for Cancer Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Personalized Medicine for Cancer Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Personalized Medicine for Cancer Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Bayer Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 55. Bayer Personalized Medicine for Cancer Product Offered
Table 56. Bayer Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Bayer Main Business
Table 58. Bayer Latest Developments
Table 59. GlaxoSmithKline Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 60. GlaxoSmithKline Personalized Medicine for Cancer Product Offered
Table 61. GlaxoSmithKline Main Business
Table 62. GlaxoSmithKline Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GlaxoSmithKline Latest Developments
Table 64. Novartis Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 65. Novartis Personalized Medicine for Cancer Product Offered
Table 66. Novartis Main Business
Table 67. Novartis Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Novartis Latest Developments
Table 69. Sanofi Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 70. Sanofi Personalized Medicine for Cancer Product Offered
Table 71. Sanofi Main Business
Table 72. Sanofi Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Sanofi Latest Developments
Table 74. Pfizer Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 75. Pfizer Personalized Medicine for Cancer Product Offered
Table 76. Pfizer Main Business
Table 77. Pfizer Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Pfizer Latest Developments
Table 79. Amgen Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 80. Amgen Personalized Medicine for Cancer Product Offered
Table 81. Amgen Main Business
Table 82. Amgen Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Amgen Latest Developments
Table 84. Merck Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 85. Merck Personalized Medicine for Cancer Product Offered
Table 86. Merck Main Business
Table 87. Merck Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Merck Latest Developments
Table 89. Bristol-Myers Squibb Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 90. Bristol-Myers Squibb Personalized Medicine for Cancer Product Offered
Table 91. Bristol-Myers Squibb Main Business
Table 92. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Bristol-Myers Squibb Latest Developments
Table 94. Ariad Pharmaceuticals (Takeda) Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 95. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product Offered
Table 96. Ariad Pharmaceuticals (Takeda) Main Business
Table 97. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Ariad Pharmaceuticals (Takeda) Latest Developments
Table 99. Eli Lilly Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 100. Eli Lilly Personalized Medicine for Cancer Product Offered
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Eli Lilly Latest Developments
Table 104. Roche Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 105. Roche Personalized Medicine for Cancer Product Offered
Table 106. Roche Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Roche Main Business
Table 108. Roche Latest Developments
Table 109. Boehringer Ingelheim Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 110. Boehringer Ingelheim Personalized Medicine for Cancer Product Offered
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Boehringer Ingelheim Latest Developments
Table 114. Johnson and Johnson Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 115. Johnson and Johnson Personalized Medicine for Cancer Product Offered
Table 116. Johnson and Johnson Main Business
Table 117. Johnson and Johnson Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Johnson and Johnson Latest Developments
Table 119. Teva Pharmaceuticals Details, Company Type, Personalized Medicine for Cancer Area Served and Its Competitors
Table 120. Teva Pharmaceuticals Personalized Medicine for Cancer Product Offered
Table 121. Teva Pharmaceuticals Main Business
Table 122. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Teva Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Personalized Medicine for Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Medicine for Cancer Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Personalized Medicine for Cancer Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Personalized Medicine for Cancer Sales Market Share by Country/Region (2023)
Figure 8. Personalized Medicine for Cancer Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Personalized Medicine for Cancer Market Size Market Share by Type in 2023
Figure 10. Personalized Medicine for Cancer in Breast Cancer
Figure 11. Global Personalized Medicine for Cancer Market: Breast Cancer (2019-2024) & ($ Millions)
Figure 12. Personalized Medicine for Cancer in Blood Cancer
Figure 13. Global Personalized Medicine for Cancer Market: Blood Cancer (2019-2024) & ($ Millions)
Figure 14. Personalized Medicine for Cancer in Gastrointestinal Cancer
Figure 15. Global Personalized Medicine for Cancer Market: Gastrointestinal Cancer (2019-2024) & ($ Millions)
Figure 16. Personalized Medicine for Cancer in Prostate Cancer
Figure 17. Global Personalized Medicine for Cancer Market: Prostate Cancer (2019-2024) & ($ Millions)
Figure 18. Personalized Medicine for Cancer in Skin Cancer
Figure 19. Global Personalized Medicine for Cancer Market: Skin Cancer (2019-2024) & ($ Millions)
Figure 20. Personalized Medicine for Cancer in Lung Cancer
Figure 21. Global Personalized Medicine for Cancer Market: Lung Cancer (2019-2024) & ($ Millions)
Figure 22. Personalized Medicine for Cancer in Others
Figure 23. Global Personalized Medicine for Cancer Market: Others (2019-2024) & ($ Millions)
Figure 24. Global Personalized Medicine for Cancer Market Size Market Share by Application in 2023
Figure 25. Global Personalized Medicine for Cancer Revenue Market Share by Player in 2023
Figure 26. Global Personalized Medicine for Cancer Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 28. APAC Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 29. Europe Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 31. Americas Personalized Medicine for Cancer Value Market Share by Country in 2023
Figure 32. United States Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Personalized Medicine for Cancer Market Size Market Share by Region in 2023
Figure 37. APAC Personalized Medicine for Cancer Market Size Market Share by Type in 2023
Figure 38. APAC Personalized Medicine for Cancer Market Size Market Share by Application in 2023
Figure 39. China Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Personalized Medicine for Cancer Market Size Market Share by Country in 2023
Figure 46. Europe Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Figure 47. Europe Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Figure 48. Germany Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 62. APAC Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 63. Europe Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 65. United States Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 66. Canada Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 69. China Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 70. Japan Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 71. Korea Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 73. India Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 74. Australia Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 75. Germany Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 76. France Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 77. UK Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 78. Italy Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 79. Russia Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 80. Spain Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 83. Israel Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 86. Global Personalized Medicine for Cancer Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Personalized Medicine for Cancer Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Personalized Medicine for Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Personalized Medicine for Cancer Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Personalized Medicine for Cancer Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Personalized Medicine for Cancer Sales Market Share by Country/Region (2023)
Figure 8. Personalized Medicine for Cancer Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Personalized Medicine for Cancer Market Size Market Share by Type in 2023
Figure 10. Personalized Medicine for Cancer in Breast Cancer
Figure 11. Global Personalized Medicine for Cancer Market: Breast Cancer (2019-2024) & ($ Millions)
Figure 12. Personalized Medicine for Cancer in Blood Cancer
Figure 13. Global Personalized Medicine for Cancer Market: Blood Cancer (2019-2024) & ($ Millions)
Figure 14. Personalized Medicine for Cancer in Gastrointestinal Cancer
Figure 15. Global Personalized Medicine for Cancer Market: Gastrointestinal Cancer (2019-2024) & ($ Millions)
Figure 16. Personalized Medicine for Cancer in Prostate Cancer
Figure 17. Global Personalized Medicine for Cancer Market: Prostate Cancer (2019-2024) & ($ Millions)
Figure 18. Personalized Medicine for Cancer in Skin Cancer
Figure 19. Global Personalized Medicine for Cancer Market: Skin Cancer (2019-2024) & ($ Millions)
Figure 20. Personalized Medicine for Cancer in Lung Cancer
Figure 21. Global Personalized Medicine for Cancer Market: Lung Cancer (2019-2024) & ($ Millions)
Figure 22. Personalized Medicine for Cancer in Others
Figure 23. Global Personalized Medicine for Cancer Market: Others (2019-2024) & ($ Millions)
Figure 24. Global Personalized Medicine for Cancer Market Size Market Share by Application in 2023
Figure 25. Global Personalized Medicine for Cancer Revenue Market Share by Player in 2023
Figure 26. Global Personalized Medicine for Cancer Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 28. APAC Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 29. Europe Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Personalized Medicine for Cancer Market Size 2019-2024 ($ Millions)
Figure 31. Americas Personalized Medicine for Cancer Value Market Share by Country in 2023
Figure 32. United States Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Personalized Medicine for Cancer Market Size Market Share by Region in 2023
Figure 37. APAC Personalized Medicine for Cancer Market Size Market Share by Type in 2023
Figure 38. APAC Personalized Medicine for Cancer Market Size Market Share by Application in 2023
Figure 39. China Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Personalized Medicine for Cancer Market Size Market Share by Country in 2023
Figure 46. Europe Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Figure 47. Europe Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Figure 48. Germany Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Personalized Medicine for Cancer Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Personalized Medicine for Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 62. APAC Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 63. Europe Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 65. United States Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 66. Canada Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 69. China Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 70. Japan Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 71. Korea Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 73. India Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 74. Australia Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 75. Germany Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 76. France Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 77. UK Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 78. Italy Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 79. Russia Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 80. Spain Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 83. Israel Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Personalized Medicine for Cancer Market Size 2025-2030 ($ Millions)
Figure 86. Global Personalized Medicine for Cancer Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Personalized Medicine for Cancer Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Military Stretcher Market Growth 2023-2029
US$ 3,660.00
March 2023
100 pages
Global Women Health and Beauty Supplement Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
112 pages
Global Adenosine Injection Market Growth 2025-2031
US$ 3,660.00
December 2025
86 pages
Global Live Poultry Vaccine Market Growth 2023-2029
US$ 3,660.00
February 2023
114 pages
Global RF Microneedling Therapy Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
November 2024
87 pages
